
Browsing restrictions can be lifted for a fee.
Chitec Technology Co., Ltd. engages in the research and development of specialty chemicals for applications in electronics, medicine, automotive, construction, and other industries worldwide. It offers UV absorbers and light stabilizers under the Chiguard name; flame retardants under the Zuran name; antioxidants under the Revonox/Deox name; photoinitiators under the Chivacure/R-gen name; and anti-reversion agents, antiozoants, optical brighteners, and auxiliary thermal stabilizers under the Chitex name. The company was founded in 1998 and is headquartered in Taipei City, Taiwan.
3430
奇鈦科
-6.12%
(-0.06)
The most recent financial report for 奇鈦科 (3430) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3430's short-term business performance and financial health. For the latest updates on 3430's earnings releases, visit this page regularly.
According to historical valuation range analysis, 奇鈦科 (3430)'s current price-to-earnings (P/E) ratio is 16.71, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 奇鈦科 (3430) reported an Operating Profit of 31M with an Operating Margin of 6.35% this period, representing a decline of 31.83% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 奇鈦科 (3430) announced revenue of 488.42M, with a Year-Over-Year growth rate of 31.66%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 奇鈦科 (3430) held Total Cash and Cash Equivalents of 253.17M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 奇鈦科 (3430) achieved the “three margins increasing” benchmark, with a gross margin of 18.98%%, operating margin of 6.35%%, and net margin of 6.43%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3430's profit trajectory and future growth potential.
According to the past four quarterly reports, 奇鈦科 (3430)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.93. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
奇鈦科 (3430)'s Free Cash Flow (FCF) for the period is 9.65M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 1.72% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.